Mr. Marc Edwards reports
KANE BIOTECH TO RELEASE FIRST QUARTER 2023 FINANCIAL RESULTS ON MAY 25, 2023 - CONFERENCE CALL TO FOLLOW
Kane Biotech Inc. will release its first quarter 2023 financial results after market close on Thursday, May 25, 2023.
Kane Biotech management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.
Participants must register for the call to receive the dial-in numbers and unique PIN to access the call seamlessly. It is recommended that you join 10 minutes before the event, though you may preregister at any time. A webcast of the call will be available on the company's website in the investor section.
About Kane Biotech
Inc.
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property (80 patents and patents pending, trade secrets, and trademarks) and products developed by the company's own biofilm research expertise and acquired from leading research institutions. StrixNB, DispersinB, Aledex, bluestem, silkstem, goldstem, coactiv+, DermaKB and DermaKB Biofilm are trademarks of Kane Biotech.
We seek Safe Harbor.
© 2024 Canjex Publishing Ltd. All rights reserved.